This represented 440,749 individuals who met Kidney Disease Improving Global Outcomes (KDIGO) clinical CKD criteria, ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The Kidney Disease: Improving Global Outcomes (KDIGO) heat map, produced by an international group of nephrologists, is a matrix of eGFR and proteinuria levels and is widely used to assess a ...

The recently proposed updates to the draft Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline, which were released for public comment in August, underscore the striking ...

The following is a summary of “Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney ...

The definition, classification and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011; 80: 17–28 CrossRef MEDLINE 2. KDIGO: KDIGO 2012 Clinical ...

Ardelyx is currently reviewing the District Court’s decision and will consider all options related to the lawsuit.

Early, personalized recommendations did not improve outcomes for hospitalized patients with acute kidney injury (AKI), the ...

KDIGO Supports HCV+ Kidneys Going To HCV– Recipients "This update is intended to assist clinicians in the care of patients with HCV infection and CKD, including patients receiving dialysis (CKD ...

including the recently updated Kidney Diseases Improving Global Outcomes (KDIGO) guideline for the management of CKD, a newly published consensus statement on renal genetics by The National Kidney ...

FILSPARI® (sparsentan) received full FDA approval as the only non-immunosuppressive treatment that significantly slows kidney function decline in ...

KDIGO, and the New England Journal of Medicine on the benefits of comprehensive genetic testing for patients with CKD," said Anthony Bleyer, MD, MS, professor of nephrology at Wake Forest ...